377 related articles for article (PubMed ID: 26906406)
1. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation.
Banerjee S; Sindberg G; Wang F; Meng J; Sharma U; Zhang L; Dauer P; Chen C; Dalluge J; Johnson T; Roy S
Mucosal Immunol; 2016 Nov; 9(6):1418-1428. PubMed ID: 26906406
[TBL] [Abstract][Full Text] [Related]
2. The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.
Muchhala KH; Kallurkar PS; Kang M; Koseli E; Poklis JL; Xu Q; Dewey WL; Fettweis JM; Jimenez NR; Akbarali HI
FASEB J; 2024 Apr; 38(8):e23603. PubMed ID: 38648368
[TBL] [Abstract][Full Text] [Related]
3. Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome.
Zhang L; Meng J; Ban Y; Jalodia R; Chupikova I; Fernandez I; Brito N; Sharma U; Abreu MT; Ramakrishnan S; Roy S
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13523-13532. PubMed ID: 31209039
[TBL] [Abstract][Full Text] [Related]
4. Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner.
Meng J; Yu H; Ma J; Wang J; Banerjee S; Charboneau R; Barke RA; Roy S
PLoS One; 2013; 8(1):e54040. PubMed ID: 23349783
[TBL] [Abstract][Full Text] [Related]
5. Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model.
Wang F; Meng J; Zhang L; Johnson T; Chen C; Roy S
Sci Rep; 2018 Feb; 8(1):3596. PubMed ID: 29483538
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use.
Kolli U; Jalodia R; Moidunny S; Singh PK; Ban Y; Tao J; Cantu GN; Valdes E; Ramakrishnan S; Roy S
Gut Microbes; 2023 Dec; 15(2):2246184. PubMed ID: 37610102
[TBL] [Abstract][Full Text] [Related]
8. Gut Homeostasis, Microbial Dysbiosis, and Opioids.
Wang F; Roy S
Toxicol Pathol; 2017 Jan; 45(1):150-156. PubMed ID: 27895265
[TBL] [Abstract][Full Text] [Related]
9. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
Shah A; Macdonald GA; Morrison M; Holtmann G
Am J Gastroenterol; 2020 Jun; 115(6):814-822. PubMed ID: 32250997
[TBL] [Abstract][Full Text] [Related]
11. Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization.
Meng J; Banerjee S; Li D; Sindberg GM; Wang F; Ma J; Roy S
Sci Rep; 2015 Jun; 5():10918. PubMed ID: 26039416
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
13. Morphine use induces gastric microbial dysbiosis driving gastric inflammation through TLR2 signalling which is attenuated by proton pump inhibition.
Ghosh N; Kesh K; Singh PK; Sharma U; Chupikova I; Ramakrishnan S; Roy S
Br J Pharmacol; 2023 Jun; 180(12):1582-1596. PubMed ID: 36585367
[TBL] [Abstract][Full Text] [Related]
14. Gut Immunity and Microbiota Dysbiosis Are Associated with Altered Bile Acid Metabolism in LPS-Challenged Piglets.
Xiao X; Cheng Y; Fu J; Lu Z; Wang F; Jin M; Zong X; Wang Y
Oxid Med Cell Longev; 2021; 2021():6634821. PubMed ID: 33833852
[TBL] [Abstract][Full Text] [Related]
15. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
16. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
17. Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
Sitkin S; Pokrotnieks J
Dig Dis Sci; 2021 Mar; 66(3):925-927. PubMed ID: 33063190
[TBL] [Abstract][Full Text] [Related]
18. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
[TBL] [Abstract][Full Text] [Related]
20. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
